Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RECQL | P46063 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.44 |
| ▸ | MME | P08473 | 2/20 | 0.44 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16449689 | 1.00 | RECQL (0.54) | RECQLMEN1KMT2ACYP3A4CYP2C9 | |
| SCHEMBL27986780 | 0.95 | MEN1 (0.50) | RECQLMEN1KMT2ACYP3A4CYP2C9 | |
| SCHEMBL11818255 | 0.86 | RECQL (0.51) | RECQLMEN1KMT2ACYP3A4CYP2C9 | |
| SCHEMBL11818250 | 0.86 | RECQL (0.51) | RECQLMEN1KMT2ACYP3A4CYP2C9 | |
| SCHEMBL1915837 | 0.86 | RECQL (0.69) | RECQLMEN1KMT2ACYP3A4CYP2C9 | |
| SCHEMBL7524611 | 0.86 | RECQL (0.54) | RECQLMEN1KMT2ACYP3A4CYP2C9 | |
| SCHEMBL6307429 | 0.86 | RECQL (0.54) | RECQLMEN1KMT2ACYP3A4CYP2C9 | |
| SCHEMBL6307440 | 0.86 | RECQL (0.54) | RECQLMEN1KMT2ACYP3A4CYP2C9 | |
| SCHEMBL1915838 | 0.86 | RECQL (0.69) | RECQLMEN1KMT2ACYP3A4CYP2C9 | |
| SCHEMBL1915834 | 0.86 | RECQL (0.69) | RECQLMEN1KMT2ACYP3A4CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112067718-B | Establishment method of muskiness rheumatalgia-relieving plaster volatile component fingerprint, standard fingerprint and application thereof | 重庆希尔安药业有限公司 | 2022-07-29 | — | — | CN | claimed |
| CN-109796338-B | Synthetic method of ozagrel intermediate p-bromomethyl cinnamate | 深圳市第二人民医院 | 2022-05-06 | — | — | CN | claimed |
| CN-112067718-A | Establishment method of muskiness rheumatalgia-relieving plaster volatile component fingerprint, standard fingerprint and application thereof | 重庆希尔安药业有限公司 | 2020-12-11 | — | — | CN | claimed |
| EP-1100432-B1 | NOVEL USES OF ASCORBYL-PHOSPHORYL-CHOLESTEROL AND COMPOSITIONS FOR PRACTICING SAME | AVON PROD INC (US) | 2007-12-19 | — | — | EP | claimed |
| EP-1100432-A4 | NOVEL USES OF ASCORBYL-PHOSPHORYL-CHOLESTEROL AND COMPOSITIONS FOR PRACTICING SAME | AVON PROD INC (US) | 2003-06-04 | — | — | EP | claimed |
| EP-1100432-A1 | NOVEL USES OF ASCORBYL-PHOSPHORYL-CHOLESTEROL AND COMPOSITIONS FOR PRACTICING SAME | AVON PRODUCTS, INC. (US) | 2001-05-23 | — | — | EP | claimed |
| US-6162450-A | Uses of ascorbyl-phosphoryl-cholesterol and compositions for practicing same | AVON PRODUCTS, INC. (US) | 2000-12-19 | — | — | US | claimed |
| WO-2000006091-A1 | NOVEL USES OF ASCORBYL-PHOSPHORYL-CHOLESTEROL AND COMPOSITIONS FOR PRACTICING SAME | AVON PRODUCTS, INC. (US) | 2000-02-10 | — | — | WO | claimed |
| CN-115141098-A | Method for preparing ozagrel intermediate through microchannel reaction | 赤峰经方医药技术开发有限责任公司 | 2022-10-04 | — | — | CN | disclosed |
| CN-112067718-B | Establishment method of muskiness rheumatalgia-relieving plaster volatile component fingerprint, standard fingerprint and application thereof | 重庆希尔安药业有限公司 | 2022-07-29 | — | — | CN | disclosed |
| CN-109796338-B | Synthetic method of ozagrel intermediate p-bromomethyl cinnamate | 深圳市第二人民医院 | 2022-05-06 | — | — | CN | disclosed |
| CN-112067718-A | Establishment method of muskiness rheumatalgia-relieving plaster volatile component fingerprint, standard fingerprint and application thereof | 重庆希尔安药业有限公司 | 2020-12-11 | — | — | CN | disclosed |
| CN-105647438-A | Adhesive composition for polarizing plate, adhesive film for polarizing plate, polarizing plate and optical display | 三星SDI株式会社 | 2016-06-08 | — | — | CN | disclosed |
| EP-1100432-B1 | NOVEL USES OF ASCORBYL-PHOSPHORYL-CHOLESTEROL AND COMPOSITIONS FOR PRACTICING SAME | AVON PROD INC (US) | 2007-12-19 | — | — | EP | disclosed |
| US-6162450-A | Uses of ascorbyl-phosphoryl-cholesterol and compositions for practicing same | AVON PRODUCTS, INC. (US) | 2000-12-19 | — | — | US | disclosed |
| WO-2000006091-A1 | NOVEL USES OF ASCORBYL-PHOSPHORYL-CHOLESTEROL AND COMPOSITIONS FOR PRACTICING SAME | AVON PRODUCTS, INC. (US) | 2000-02-10 | — | — | WO | disclosed |
| CN-1040982-C | Pharmaceutical compounds | LILLY INDUSTRIES LTD (GB) | 1998-12-02 | — | — | CN | disclosed |
| CN-1034938-C | Pharmaceutical compounds | LILLY INDUSTRIES LTD (GB) | 1997-05-21 | — | — | CN | disclosed |
| CN-1092072-A | Medicinal compositions | LILLY INDUSTRIES LTD (GB) | 1994-09-14 | — | — | CN | disclosed |
| CN-1073437-A | Medicinal compound | LILLY INDUSTRIES LTD (GB) | 1993-06-23 | — | — | CN | disclosed |